Butyric acid causes morphological changes in cultured chondrocytes through alterations in the extracellular matrix.
Butyric acid induces characteristic changes in the morphology of chick embryo chondrocytes. Chick embryo chondrocytes when cultured in the absence of butyrate exhibit a spherical morphology and synthesize cartilage-specific chondroitin sulfate proteoglycan (CSPG). When these cultures are initiated and maintained in the presence of butyric acid, chondrocytes exhibit a mesenchymal morphology, a 90% reduction in the synthesis of CSPG, and a 75% reduction in DNA synthesis. The reduced synthesis of CSPG and DNA was shown not to be dependent on the morphological change. Chondrocytes require CSPG in order to express a spherical morphology, since including chondroitinase ABC in the culture media caused the cells to spread. In addition, the treatment of chondrocytes with purified CSPG prior to culture in media containing butyric acid resulted in spherical cells. The butyrate-induced spreading was shown to require either serum or fibronectin and could be prevented with antiserum against chick cell-surface fibronectin (cFn). Cell-surface fibronectin, which was present on both spherical and flattened chondrocytes, organized into fibrils beneath cells which spread. Increased fibronectin synthesis was not responsible for the butyrate-induced morphological change. From this evidence, it is concluded that the mechanism by which butyrate alters the morphology of these cells in culture involves inhibiting CSPG synthesis, thus preventing CSPG accumulation in the extracellular matrix (ECM). The absence of CSPG in the ECM allows fibronectin to mediate spreading of chondrocytes in culture.
Bretton
R H
RH
Department of Zoology, University of Vermont, Burlington 05401.
Pennypacker
J P
JP
D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D020148:Butyric Acid; D002356:Cartilage / Q000187:drug effects*; D002478:Cells, Cultured; D002642:Chick Embryo; D002808:Chondroitin Lyases / Q000378:metabolism; D011508:Chondroitin Sulfate Proteoglycans / Q000096:biosynthesis; D005109:Extracellular Matrix / Q000187:drug effects*; D005353:Fibronectins / Q000493:pharmacokinetics / Q000494:pharmacology; D013431:Sulfates / Q000493:pharmacokinetics
D002087:Butyrates; D011508:Chondroitin Sulfate Proteoglycans; D005353:Fibronectins; D013431:Sulfates; D020148:Butyric Acid; D002808:Chondroitin Lyases